Effect of change in sodium excretion on change in blood pressure corrected for measurement error: The Trials of Hypertension Prevention, Phase I

American Journal of Epidemiology

Volumn 148, Issue 5, 1998, Pages 431-444

  Cook, Nancy R ^a   Kumanyika, Shiriki K ^b   Cutler, Jeffrey A ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Blood pressure; Longitudinal studies; Potassium; Regression analysis; Sodium

Indexed keywords

ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; REGRESSION ANALYSIS; SODIUM EXCRETION; SODIUM INTAKE; SYSTOLIC BLOOD PRESSURE;

EID: 0032167517     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009668     Document Type: Article

References (30)

1. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? I. Analysis of observational data among populations. Br Med J 1991;302:811-15.
2. Frost CD, Law MR, Wald NJ. By how much does dietary salt reduction lower blood pressure? II. Analysis of observational data within populations. Br Med J 1991;302:815-18.
3. Intersalt Cooperative Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Br Med J 1988; 297:319-28.
4. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III. Analysis of data from trials of salt reduction. Br Med J 1991;302:819-24.
5. Cutler JA, Follman D, Elliot P, et al. An overview of randomized trials of sodium reduction and blood pressure. Hypertension 1991;17[suppl I]:I-27-I-33.
6. Midgley JP, Matthew AG, Greenwood CMT, et al. Effect of reduced dietary sodium on blood pressure. JAMA 1996;275: 1590-7.
7. Lenfant C. High blood pressure: some answers, new questions, continuing challenges. (Editorial). JAMA 1996;275:1604-6.
8. Cutler JA, Follman D, Allender PS. Randomized trials of sodium reduction: an overview. Am J Clin Nutr 1997; 65(suppl):643S-651S.
9. Liu K. Measurement error and its impact on partial correlation and multiple linear regression analyses. Am J Epidemiol 1988; 127:864-74.
10. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. I. Prolonged differences in blood pressure: prospective observational studies corrected for regression dilution bias. Lancet 1990;131:589-96.
11. Dyer AR, Elliot P, Shipley M, et al. Urinary electrolyte excretion in 24 hours and blood pressure in the INTERSALT study. II. Estimates of electrolyte-blood pressure associations corrected for regression dilution bias. Am J Epidemiol 1994; 139:940-51.
12. Elliot P, Stamler J, Nichols R, et al. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Br Med J 1996;312:1249-53.
13. Davey Smith G, Phillips AN. Inflation in epidemiology: "The proof and measurement of two things" revisited. Br Med J 1996;312:1659-61.
14. Dyer AR, Elliot P, Marmot M, et al. Commentary: strength and importance of the relation of dietary salt to blood pressure. Br Med J 1996;312:1661-4.
15. Kumanyika SK, Hebert PR, Cutler JA, et al. Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, Phase I. Hypertension 1993;22:502-12.
16. The Trials of Hypertension Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA 1992;267:1213-20.
17. Satterfield S, Cutler JA, Langford HG, et al. Trials of Hypertension Prevention: Phase I design. Ann Epidemiol 1991;1: 455-71.
18. Cook NR, Rosner BA. Screening rules for determining blood pressure status in clinical trials: application to the Trials of Hypertension Prevention. Am J Epidemiol 1993;137:1341-52.
19. Satterfield S, Borhani NO, Whelton P, et al. Recruitment for Phase I of the Trials of Hypertension Prevention. Am J Prev Med 1993;9:237-43.
20. Murray GD, Findlay JG. Correcting for the bias caused by drop-outs in hypertension trials. Stat Med 1988;7:941-6.
21. Smith L, Rosner B. Estimation of variance components for censored data with applications to blood pressure variability. Stat Med 1991;10:1441-52.
22. Rubin DB. Inference and missing data. Biometrika 1976;63: 581-92.
23. Dixon WJ. BMDP statistical software. Berkeley, CA: University of California Press, 1988.
24. SAS Institute. SAS/STAT user's guide, version 6. 4th ed. Vol 2. Cary, NC: SAS Institute Inc, 1989.
25. Fuller WA. Measurement error models. New York: Wiley, 1978.
26. Buonaccorsi JP. Measurement error models for gypsy moth studies In: Lange N, Ryan L, Billard L, et al, eds. Case studies in biometry. New York: Wiley, 1994:59-80.
27. Dyer AR, Shipley M, Elliott P, et al. Urinary electrolyte excretion in 24 hours and blood pressure in the INTERSALT Study. I. Estimates of reliability. Am J Epidemiol 1994;139: 927-39.
28. Stamler R. Implications of the INTERSALT Study. Hypertension 1991;17(suppl I):I-16-I-20.
29. Cook NR, Cohen J, Hebert PR, et al. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 1995;155:701-9.
30. The Trials of Hypertension Prevention Collaborative Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: the Trials of Hypertension Prevention, Phase II. Arch Intern Med 1997;157: 657-67.